Paige Alba logo

Paige Alba

AI-powered pathology co-pilot integrating pathology, radiology, and clinical data for cancer diagnostics and precision medicine.

Solution by Paige
Visit website

Overview

Paige Alba™ is an AI-powered pathology co-pilot developed by Paige.ai, designed to transform the way pathologists, oncologists, and clinicians approach cancer diagnostics. By seamlessly integrating pathology, radiology, and clinical data into a single unified experience, Alba represents a significant step forward in precision medicine and integrated diagnostics.

Built on Paige's industry-leading AI-assisted diagnostic applications and foundation model technology, Alba combines cutting-edge agentic AI with intuitive voice and text interaction. The platform is intended to streamline clinical workflows, reduce administrative burden, and deliver real-time insights that empower diagnostic teams with greater confidence and efficiency in their day-to-day work.

How Alba Works

  • Alba leverages next-generation generative AI to automate routine tasks, analyze pathology images, and provide prompt clinical insights.
  • All functionality is delivered within an intuitive, interactive interface that supports both voice commands and chat-based interaction.
  • The platform draws on Paige's AI-assisted diagnostic applications to automatically process digitized slides and surface preliminary findings for clinician review.

Key Capabilities

  • Data Aggregation: Alba consolidates pathology reports, radiology findings, and patient history into a comprehensive summary, giving pathologists and oncologists a holistic picture of each patient at a glance.
  • Routine Task Automation: From ordering additional stains to generating pathological reports, Alba reduces administrative burden so pathologists can focus their attention on complex cases.
  • AI-Powered Image Analysis and Cancer Detection: Utilizing Paige's AI-assisted diagnostic applications, Alba automatically analyzes digitized slides, highlights areas suspicious for cancer, and generates preliminary insights for clinician review.
  • Molecular Biomarker Screening: Through Paige OmniScreen™ technology, Alba simultaneously screens for multiple molecular biomarkers associated with the presence of cancer, helping to inform treatment options.
  • Multidisciplinary Collaboration: Alba is designed to support tumor board meetings and collaborative clinical environments, offering AI-driven insights to inform critical decision-making across multidisciplinary teams.
  • Voice and Chat Assistance: Clinicians can interact with Alba using voice commands or chat, enabling hands-free workflow automation and instant case guidance.
  • Automated Pathology Report Generation: Alba accelerates reporting and documentation processes, improving the overall efficiency of clinical workflows.

Availability and Intended Use

  • Alba is currently in beta and available for trial, allowing institutions to explore its capabilities in transforming clinical workflows.
  • Content generated by Alba is intended for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
  • Regulatory status varies by AI-assisted diagnostic application; when Research Use Only (RUO) products are used alongside IVD products, the integrated workflow is designated for research use only and cannot be used for diagnostic procedures.

Paige Alba is positioned as the future of AI-driven precision medicine, bringing together integrated diagnostics, agentic AI, and multidisciplinary collaboration tools into a single platform purpose-built for oncology and pathology workflows.

Meta

Domain
Digital Pathology & Imaging
Subdomain
Digital Pathology Analysis
Software type(s)
Copilot / Assistant
Deployment type(s)
Cloud / SaaS
Industry vertical(s)
Academic / ResearchBiotechCRODiagnostics / IVDPharma
Development stage(s)
Preclinical / Pre-MarketClinical
Target user(s)
Research ScientistClinical / Diagnostic ProfessionalMedical Affairs Professional
Compliance standard(s)
21 CFR Part 11
Tag(s)
Uses AI